Method of detecting amyloid-containing lesions by autofluorescence
AssigneeNymox Corporation
InventorsPaul A. Averback, Celine Dupuis
Life of this patent
Estimating the term…
Loading patent…
AssigneeNymox Corporation
InventorsPaul A. Averback, Celine Dupuis
Estimating the term…
Disclosed is a method of detecting amyloid-containing deposits in a mammal without administering exogenous chemicals such as fluorophores or chromophores. The method includes subjecting tissue of a mammal, preferably tissue of a mammal suspected of having at least one form of amyloidosis to autofluorescence-initiation, preferably by subjecting the tissue to at least excitation incident radiation from a light source having a wavelength of light within the range of from about 360 to about 370 nm, and more preferably to illumination incident radiation from a light source having wavelengths in the visible spectrum, to produce an emitted light signal beam and a reflected light signal beam. The method also preferably includes detecting the presence of emitted light having a wavelength of from about 400 nm to about 460 nm. The method can be used to diagnose amyloidosis in living mammals using relatively non-invasive imaging apparatus, and it can be used to monitor the efficacy of treatment, or screen effective treatments for amyloidosis.
1) A method of detecting amyloidosis comprising:
11) A method of detecting amyloidosis comprising:
21) A system for detecting amyloidosis in a mammal, comprising:
34) A method of detecting amyloidosis comprising:
39) A method of detecting amyloidosis comprising:
43) A method of detecting amyloidosis comprising:
46) A method of detecting autofluorescence comprising:
Dependencies are inferred from the claim text.